Pancreatic Cancer Research

ResearcherUniversity of MichiganNo recent work listed

Ulka N. Vaishampayan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5800-4571; OpenAlex author ID A5073593424. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 2 papers

Papers 2

  1. Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation. Co-author DOI 10.1002/onco.13758↗
  2. An evaluation of olaparib for the treatment of pancreatic cancer. Co-author DOI 10.1080/14656566.2020.1837113↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shumei Kato · 1 shared paper, 2021 · strength 0.13
  2. Dana Backlund Cardin · 1 shared paper, 2021 · strength 0.13
  3. Patricia Mucci LoRusso · 1 shared paper, 2021 · strength 0.13
  4. Joseph W. Kim · 1 shared paper, 2021 · strength 0.13
  5. Steven R. Grossman · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.